Stockscreener 앱 받기
7.43
4.37%
-0.3399
시간 외 거래:
7.31
-0.12
-1.62%
전일 마감가:
$7.7699
열려 있는:
$7.8
하루 거래량:
11,801
Relative Volume:
0.04
시가총액:
$5.40M
수익:
$7.83M
순이익/손실:
$-8.28M
주가수익비율:
-0.4403
EPS:
-16.8761
순현금흐름:
$-6.85M
1주 성능:
-0.93%
1개월 성능:
+2.20%
6개월 성능:
+20.93%
1년 성능:
-94.43%
1일 변동 폭
$7.1501
$7.8255
1주일 범위
$7.1501
$7.8255
52주 변동 폭
$3.0765
$128.62
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
7.43 | 5.64M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-27 | 개시 | ROTH MKM | Buy |
Moolec Science Sa 주식(MLEC)의 최신 뉴스
MLEC Q2 2025 Earnings: Narrower Loss than Expected as Stock RisesAnnual Earnings Summary - Newser
MLEC Q2 2025 Earnings: EPS Surprises to the Upside as Pre-Revenue Science Company Narrows LossEBITDA Margin Trends - Newser
Why Is Moolec Science S.A. (MLEC) Stock Down Today? - Meyka
MLEC Moolec EPS beats estimates but revenue plummets 285 yearoveryear shares declineEarnings Outlook Update - Newser
MSN Money - MSN
Moolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGM - TipRanks
Moolec Science shareholders approve financials, re-elect directors and auditor - Investing.com
[6-K] Moolec Science SA Current Report (Foreign Issuer) | MLEC SEC FilingForm 6-K - Stock Titan
Moolec Science completes 2026 safflower planting campaign By Investing.com - Investing.com South Africa
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026 - Meyka
Moolec Science completes 2026 safflower planting campaign - Investing.com
Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States - ACCESS Newswire
Safflower oil tops 60% GLA as Moolec finishes 2026 US planting push - Stock Titan
Moolec Science Swings to Profit on Subsidiary Deconsolidation in Latest Interim Results - TipRanks
Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base - TipRanks
Moolec hits $11.3M equity to satisfy Nasdaq listing rules - Stock Titan
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period - galvnews.com
Moolec Science (NASDAQ: MLEC) restores Nasdaq equity compliance - Stock Titan
TradingKey - TradingKey
MLEC stock extends its relentless rally, sees 35% boost today after change in shareholding - MSN
MLEC (Moolec) EPS beats estimates but revenue plummets 28.5% year-over-year, shares decline.IPO - newser.com
The working capital efficiency at Moolec (MLECW) | MLECW QX Earnings: Moolec Warrant Reports No Earnings DataDecline Phase - newser.com
MLEC Insider Filing: Director Core Daniel Joaquin Ownership Disclosure May 2026 - Meyka
MLECW Price History for Moolec Science Sa WT Stock - Barchart.com
MLEC SEC FilingsMoolec Science 10-K, 10-Q, 8-K Forms - Stock Titan
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Sahm
Why Is Moolec Science Stock Up Despite Weak Market Sentiment? - Sahm
Moolec Science completes GLASO1 safflower industrialization phase By Investing.com - Investing.com Australia
Moolec Science completes GLASO1 safflower industrialization phase - Investing.com
Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications - ACCESS Newswire
High-purity safflower oil pushes Moolec beyond pet food toward energy - Stock Titan
MLEC Insider Filing: Director Core Daniel Joaquin Reports Ordinary Shares, April 29, 2026 - Meyka
Contact | Statesman-Examiner - FinancialContent
Moolec Science Sa (MLEC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
0.12%
자본화:
|
볼륨(24시간):